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Abstract
OBJECTIVE: To study the effects of extracts from
Honghua (Flos Carthami) on lipopolysaccharide in-
duced nitric oxide (NO) production in RAW 264.7
cells and the influence of the extracts on yeast
α-glucosidase activity. The total flavonoid content
of the extracts was also determined.
METHODS: Cytotoxicity of the extracts to RAW
264.7 cells was evaluated by the ATPlite™ method.
Inhibitory effects of the extracts on NO production
were evaluated by Griess assay. Curcumin was used
as a positive control. Screening of extracts for po-
tential α-glucosidase inhibitors was done by a fluo-
rometric assay. The assay was based on the hydroly-
sis of 4-methylumbelliferyl-a-D-glucopyranoside to
form the fluorescent product, 4-methylumbellifer-
one. Acarbose was used as a positive control. The
total flavonoid content was tested using kaempfer-
ol as the standard.
RESULTS: There were significant inhibitory effects
onNOproductionwhentheextractswere25-100 µg/
mL (P<0.05) and curcumin was 2-4 µg/mL (P<
0.001). The extracts showed an inhibitory effect on
α-glucosidase activity at the concentrations of
15.6-125 µg/mL with a half maximal (50%) inhibito-
ry concentration (IC50) of (32.8 ± 5.7) µg/mL, com-
pared with the IC50 of acarbose at (1.8±0.4) µg/mL.
There was a significant difference between the two
IC50 values (P<0.001). The total content of flavo-
noids per gram of dried herb was 1.14 mg.
CONCLUSION: Honghua (Flos Carthami) showed in-
hibitory effects on NO production in activated RAW
264.7 macrophage cells and an inhibitory effect on
yeast α-glucosidase. There might be a relationship
between these pharmacological effects and its fla-
vonoid content.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Since 1978, when diabetes mellitus (DM) with blood
stasis syndrome was proposed by Dr. Chenyu Zhu,1
some progress has been made in the treatment of DM
with blood-activating and stasis-resolving herbs. Hong-
hua (Flos Carthami) is the tubular flower of Carthamus
tinctorius L., a Compositae plant. Honghua (Flos Car-
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thami) can promote blood circulation and remove
blood stasis. Honghua (Flos Carthami) injection was
first successfully developed by Shanxi Provincial Peo-
ple's Hospital in 1974.2 In the past 40 years, it has
played a positive role in the treatment of DM and its
complications.3
Previous studies have shown that macrophages are the
major cells involved in the early inflammatory infiltra-
tion of pancreatic islets. The free radicals and cytokines
released by the activated macrophages can directly dam-
age b-cells by inducing the generation of free radicals
in b-cells.4 The infiltration of pancreatic islets by mac-
rophages, decreased activity of superoxide dismutase in
pancreatic islets, and increased level of nitric oxide
(NO) are early pathological changes of DM.5 On the
other hand, α-glucosidase is a critical enzyme in carbo-
hydrate metabolism. α-glucosidase inhibitors can be
used to prevent and treat postprandial hyperglycemia
and relieve hyperinsulinemia, and therefore play an im-
portant role in the treatment of typeⅡ DM.
In this study, Honghua (Flos Carthami) was extracted
according to the method for preparing Honghua (Flos
Carthami) injection as established by the China Food
and Drug Administration (CFDA). The effects of the
Honghua (Flos Carthami) extracts on the release of
NO from lipopolysaccharide (LPS)-activated mouse
RAW 264.7 macrophages and on the activity of α-glu-
cosidase were studied and the content of total flavo-
noids in the extracts was determined.
MATERIALS ANDMETHODS
Preparation of sample
Honghua (Flos Carthami) was purchased from Shanxi
Double-Crane Pharmaceutical Co., Ltd., (Taiyuan,
China) and was identified by the Department of Phar-
macy of Shanxi Provincial People's Hospital. The Hon-
ghua (Flos Carthami) extract solution was prepared as
follows.6 Honghua (Flos Carthami) (500 g) was added
into water and decocted three times for 1 h, 50 min,
and 30 min. The decoction solutions were combined
and filtered. The filtrate was concentrated to a relative
density of 1.16-1.26, and ethanol was added to achieve
an alcohol content of 70% . After refrigeration at
4℃-8℃ for 48 h, the solution was filtered. Ethanol
was removed from the filtrate, which was then concen-
trated to a relative density of 1.10-1.14. Additional eth-
anol was added to achieve an alcohol content of 80%,
and the solution was filtered after it was refrigerated
and set aside for another 48 h. Ethanol was removed
from the filtrate, which was then concentrated to a rela-
tive density of 1.16-1.20. Thereafter, a 10-fold volume
of water was added, and the solution was refrigerated,
set aside for 16-24 h, and then filtered. The filtrate was
concentrated to a relative density of 1.02-1.04, and
was adjusted to a pH of 7.5-8.0 with 20% sodium hy-
droxide solution. It was heated at 115℃ for 15 min, re-
frigerated, and set aside for 120 h. An appropriate
amount of activated carbon was added, and the mix-
ture was stirred, filtered, ultra-filtered, and then adjust-
ed to pH 7.5-8.0 again with 20% sodium hydroxide so-
lution. Water for injection was added to a total volume
of 1000 mL, thereby formulating an extract solution
containing 0.5 g of crude drug per mL.
A 5-mL aliquot of the above Honghua (Flos Carthami)
extract solution was pipetted and dried in vacuo to a
constant weight. The resultant extracts were weighed as
260.90 mg and the yield was calculated as 104.36 mg of
extract per gram of crude drug. The extract solution
and the dried extracts were both stored at 0℃-4℃ un-
til use. The extract solution was used for the determina-
tion of the content of total flavonoids, and the extract
were used to study their effects on the cytotoxicity to
RAW264.7 cells, the NO production from LPS-acti-
vated RAW 264.7 cells, and the activity of α-glucosi-
dase. The extracts were re-dissolved in Milli-Q (MQ)
water at a desired concentration when the experiment
was performed.
Reagents and instruments
Lipopolysaccharide (LPS), Griess reagent (0.1%
N-[1-naphthyl] ethylenediamide dihydrochloride, 1%
sulfanilamide in 5% phosphoric acid), 50 mM sodium
acetate buffer (pH 5.5), and 100 mM sodium glycinate
buffer (pH 10.6) were all prepared in-house from re-
agents purchased from Wako Chemicals USA Inc.
(Richmond, VA, USA). Luminescent ATPlite ™ assay
kit was obtained from PerkinElmer (Boston, MA,
USA). Yeast α-glucosidase (EC3.2.1.20), 4-methylum-
belliferyl-a-D-glucopyranoside (4-MUG), dimethyl
sulfoxide (DMSO), sodium nitrite, kaempferol, cur-
cumin, and methanol were all obtained from Sigma-Al-
drich China (Shanghai, China). Acarbose (Glucobay,
50 mg/tablet) was obtained from Bayer Health Care
Company Ltd. (Beijing, China).
The Victor2 plate reader (Wallac, Turku, Finland), the
96-well polystyrene microplates and Wallac Delfia
1296-003 shaker were purchased from PerkinElmer
(Boston, MA, USA).
Cell source and culture
RAW 264.7 cell lines were purchased from the Ameri-
can Type Culture Collection (Manassas, VA, USA) and
were cultured in colorless Dulbecco's modified Eagle's
medium (DMEM) supplemented with heat inactivated
fetal bovine serum (10%), D-glucose (3.5 mg/mL), Na
pyruvate (100 mM), L-glutamine (2 mM), penicillin
(100 U/mL), streptomycin (100 μg/mL), and ampho-
tericin B (250 μg/mL) at 37℃ and 5% CO2.
Effects of cytotoxicity of Honghua (Flos Carthami) to
RAW 264.7 cells
RAW264.7 cells were plated in a 96-well plate at
1×105 cells/mL. Honghua (Flos Carthami) or curcumin
(1 μL) was added to a cell suspension (99 μL) and cul-
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tured at 37℃, 5% CO2 for 24 h. Viable cell count was
determined using a luminescent ATPlite™ test. Solvent
controls (1 μL) were also tested separately according to
the above methods. Each concentration and solvent
control was assayed six times.
The Honghua (Flos Carthami) extracts were tested at
31.3, 62.5, 125, 250, 500 μg/mL, and MQ water was
the solvent control. Curcumin,7 the positive control,
was tested at 4.3, 9.4, 20.7, 45.5, 100 μg/mL, and
DMSO was the solvent control.
Effects of Honghua (Flos Carthami) on
LPS-activated RAW 264.7 cells
Activity of inducible nitric oxide synthase (iNOS) was
determined on RAW 264.7 cells (148 μL, plated at 1×
106 cells/mL). Solvent (1 μL) was added to the cells,
and then cells were stimulated with LPS (1 μL, diluted
with DMEM, 0.05 μg/mL) after 2 h. Nitrite, a stable
end-product of NO metabolism, was then measured af-
ter 22 h using the Griess reaction.8 Culture media of
the RAW 264.7 cells (100 μL) was mixed with an
equal volume of Griess reagent, followed by spectro-
photometric measurement at 550 nm. Nitrite concen-
trations in the culture media were determined by com-
parison with a sodium nitrite standard curve.
To test the influence of different solvents, there were
separate LPS and solvent controls for Honghua (Flos
Carthami) and curcumin. The LPS control for Hong-
hua (Flos Carthami) was MQ water (1 μL) in cell sus-
pension, and others were as above. The Honghua (Flos
Carthami) group was the extracts (1 μL) in cell suspen-
sion with test concentrations of 12.5, 25, 50, and 100 µg/
mL. The solvent control for Honghua (Flos Carthami)
was MQ water (1 μL) in cell suspension and LPS was
replaced by 1 μL DMEM.
Curcumin was the positive control. The LPS control
for curcumin was DMSO (1 μL) in cell suspension,
and others were as above. The curcumin group was cur-
cumin (1 μL) in cell suspension with test concentra-
tions of 2 and 4 µg/mL. The solvent control for cur-
cumin was DMSO (1 μL) and DMEM (1 μL). Each
concentration was assayed six times.
Determination of effect of Honghua (Flos Carthami)
on yeast α-glucosidase activities
A fluorometric assay was used for the screening of po-
tential yeast α-glucosidase inhibitors. The assay was
based on 4-MUG, the substrate, being hydrolyzed byα-glucosidase to yield the fluorescent product, 4-meth-
ylumbelliferone (4-MU).9α-glucosidase group: a 1 mM stock substrate solution
of 4-MUG was diluted with 50 mM sodium acetate
buffer to give a final assay concentration of 84 μM.
The substrate (45 μL) was added to 96-well plates con-
taining 50 μL α-glucosidase and 5 μL sodium acetate
buffer. The contents of the microplate were mixed on
an orbital shaker for 30 s and incubated for 20 min at
37℃ . The reaction was stopped by the addition of
100 mM sodium glycinate (100 μL). The plate was
shaken for a further 30 s, and the fluorescence mea-
sured at lex 355 nm, lem 460 nm.
For the test samples and control, instead of 5 μL buf-
fer, 5 μL Honghua (Flos Carthami) or acarbose were
added to wells and subsequent assay steps were carried
out as above. The test concentrations of Honghua (Flos
Carthami) were as follows: 15.6, 31.3, 62.5, and 125 μg/
mL. Acarbose was the positive control, and its concen-
tration was 0.3, 0.6, 1.3, and 2.5 μg/mL. Sodium ace-
tate buffer was used as a negative control. Instead ofα-glucosidase, 50 μL sodium acetate buffer was added
to the well. Each concentration was assayed six times.
Determination of total flavonoids6
Preparation of reference solution: a reference solution
of kaempferol was prepared in methanol at 0.1 mg/
mL. Preparation of standard curve: 1.0, 2.0, 3.0, 4.0,
5.0, and 6.0 mL of the reference solution were added
into 25-mL volumetric flasks and made up to volume
with methanol. After shaking, 2.0 mL of each of the
above solutions were added into a 10-mL test tube
with a stopper. Then 1.0 mL of 0.1 M aluminum tri-
chloride solution and 2.0 mL of methanol were added
into the test tube, shaken well, and heated in a water
bath at 40℃ for 20 min. The test tube was removed
from the water bath and cooled down to room temper-
ature. With a corresponding reagent as the blank, the
absorbance at wavelength of 422 nm was measured ac-
cording to the UV-Vis spectrophotometry as described
in Appendix VA of the Chinese Pharmacopoeia 2010,
VolumeⅠ. A standard curve was plotted using the ab-
sorbance values as the Y-axis and the concentrations as
the X-axis.
Determination of total flavonoids: 0.5 mL of the Hon-
ghua (Flos Carthami) extract solution was added into a
50-mL volumetric flask, made up to volume with
methanol, and shaken well (test solution). 2.0 mL of
the test solution was added to a 10 mL test tube with a
stopper and its absorbance was measured according to
the method as described in the preparation of standard
curve. The blank solution was prepared by the same
steps as above except it contained 2.0 mL of the test so-
lution, and 3.0 mL of methanol. The total flavonoid
content, as kaempferol equivalents in the test solution,
was calculated after comparison with the kaempferol
standard curve.
Statistical analysis
Growth inhibition to RAW 264.7 cells (% ) =(A [sol-
vent control]−A [Honghua (Flos Carthami) or curcum-
in])/A (solvent control)×100. Inhibitory effect on NO
production (%)=(Nitrite [LPS control]−Nitrite [Hong-
hua (Flos Carthami) or curcumin])/(Nitrite [LPS con-
trol] −Nitrite [solvent control]) ×100. Inhibitory effect
on α-glucosidase activities (%)=(A [α-glucosidase] −A
[Honghua (Flos Carthami) or acarbose])/(A [α-glucosi-
dase] − A [negative]) × 100. All data are expressed as
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mean±standard deviation. SPSS software (version 12.0,
SPSS Inc., Chicago, IL, USA) was used for statistical
analysis. Student's t-test was used for inter-group com-
parison. P<0.05 was considered statistically significant.
RESULTS
In vitro cytotoxicity effect of Honghua (Flos
Carthami) on RAW 264.7 cell line
The Honghua (Flos Carthami) extract inhibited the
growth of RAW 264.7 cells in the range of 250-
500 μg/mL, and curcumin in the range 9.4-100 μg/
mL (Table 1). If the growth inhibition to RAW 264.7
cells was below 10% , the concentrations of samples
were considered safe.10 The concentrations of Honghua
(Flos Carthami) at 12.5, 25, 50, and 100 μg/mL, and
curcumin at 2 and 4 μg/mL were tested for the NO as-
say.
Influence of solvent on RAW 264.7 cells
Honghua (Flos Carthami) solvent control (nitrite) was
not significantly different from the curcumin solvent
control (P>0.05). The two LPS controls were also not
significantly different (P>0.05) (Table 2).
Influence of LPS on RAW 264.7 cells
NO production was significantly higher after LPS stim-
ulation compared to that in the solvent control in both
cases (P<0.001) (Table 2).
Group
Honghua (Flos Carthami)
Curcumin
Concentration (μg/mL)
500
250
125
62.5
31.3
100
45.5
20.7
9.4
4.3
Growth inhibition (%)
25.62±3.17
13.51±1.72
4.21±0.51
2.56±0.31
0.61±0.09
97.81±12.93
93.53±10.16
33.18±3.91
22.33±3.21
3.01±3.77
Table 1 In vitro cytotoxicity effect of Honghua (Flos Carthami) to RAW 264.7 cells ( xˉ ±s)
Notes: Honghua (Flos Carthami): RAW 264.7 cells were treated with Honghua (Flos Carthami) with Milli-Q (MQ) water as a solvent con-
trol; Curcumin was used as control: RAW 264.7 cells were treated with curcumin and dimethyl sulfoxide (DMSO) as a solvent control.
Group
Honghua (Flos Carthami)
LPS control [for Honghua (Flos Carthami)]
Solvent control [for Honghua (Flos Carthami)]
Curcumin
LPS control (for curcumin)
Solvent control (for curcumin)
Concentration (μg/mL)
100
50
25
12.5
-
-
4
2
-
-
Nitrite (μM)
30.8±4.3a
32.7±3.9a
36.1±4.5a
41.2±4.9
43.8±5.7b
4.9±0.7
16.9±1.1c
24.1±3.3c
42.7±4.1d
4.6±0.9
Percentage of nitrite inhibition (%)
33.4±4.2
28.5±3.5
19.8±2.6
6.7±0.7
-
-
67.7±5.2
48.8±5.3
-
-
Table 2 Inhibitory effect of Honghua (Flos Carthami) on nitric oxide production ( xˉ ±s)
Notes: Honghua (Flos Carthami): RAW 264.7 cells were treated with lipopolysaccharide [LPS, in Dulbecco's modified eagle medium
(DMEM)] and Honghua (Flos Carthami) [in Milli-Q (MQ) water]; LPS control for Honghua (Flos Carthami): treated with LPS and MQ
water; Solvent control for Honghua (Flos Carthami): treated with DMEM and MQ water; Curcumin was used as positive control and
treated with LPS and curcumin [in dimethyl sulfoxide (DMSO)]; LPS control for curcumin: treated with LPS and DMSO; solvent con-
trol for curcumin: treated with DMEM and DMSO. aP<0.05, Honghua (Flos Carthami) compared with its LPS control; bP<0.001, LPS
control for Honghua (Flos Carthami) compared with its solvent control; cP<0.001, compared with its LPS control; dP<0.001, compared
with its solvent control.
365
JTCM |www. journaltcm. com June 15, 2014 |Volume 34 | Issue 3 |
Liao H et al. / Experimental Study
Inhibitory effect of Honghua (Flos Carthami) on NO
production
Cells treated with extracts had significantly less LPS-
stimulated NO production at 25, 50, and 100 μg/mL
than that in the LPS control (P=0.040, 0.003, 0.001,
respectively). The inhibitory effect on NO production
of curcumin was 48.8% (at 2 μg/mL) and 67.7% (at
4 μg/mL), and was significantly different from its LPS
control (P<0.001) (Table 2).
Inhibitory effect of Honghua (Flos Carthami) on
yeast α-glucosidase activities
The extracts of Honghua (Flos Carthami) inhibited
yeast α-glucosidase activity in the range of 15.6-125μg/mL. Half maximal (50%) inhibitory concentration
on yeast α-glucosidase activities (IC50) of the extracts
was (32.8±5.7) μg/mL, and was significantly different
from acarbose [(1.8±0.4) μg/mL, P<0.001] (Table 3).
Content of total flavonoids
Total flavonoid concentration was 0.57 mg kaempferol
equivalents per 1 mL Honghua (Flos Carthami) extract
solution and 1.14 mg kaempferol equivalents per 1 g
dried herb.
DISCUSSION
DM is a common disease, of which 90%-95% is typeⅡ DM. Its etiology is so complex that the pathogene-
sis has not been fully elucidated. Current studies sug-
gest that NO plays an important role in the initiation
of type Ⅱ DM, insulin resistance and secondary ef-
fects, and the dysfunction of islet b-cells.
In a study on an alloxan diabetic rat model, the serum
NO content in the model group was significantly high-
er than that in the normal control group, accompanied
by a decreased serum insulin level and an elevated fast-
ing blood glucose level. In the early stage of DM, be-
cause of the increased generation of NO from glomeru-
lar endothelial cells and the lipotoxicity prevalent in pa-
tients with DM, unsaturated fatty acids up-regulate iN-
OS to generate an excess of NO. The excess NO pro-
duces free radicals such as peroxynitrite ions, which are
cytotoxic and damage the structure and function of
b-cells.11
Clinical studies of modern Chinese medicine have
found that the incidence of DM with blood stasis syn-
drome is about 60%. Promoting blood circulation for
removing blood stasis is considered one of the major
methods for treating DM.12 Gingko leaf extracts can
promote blood circulation and remove blood stasis and
are capable of significantly reducing the levels of blood
glucose, blood insulin, total cholesterol, and triglycer-
ides in rats with type Ⅱ DM. Further studies have
found that gingko leaf extracts can inhibit total NOS
activity and the expression of iNOS mRNA in diabetic
rat macrophages. This suggests that it is possible for
gingko leaf extracts to reduce the generation of NO by
inhibiting the expression and activity of iNOS genes in
macrophages, thereby facilitating the improvement of
various indices of diabetic rats.5,13
In a multi-center prospective cohort study on the treat-
ment of diabetic nephropathy with combined Chinese
and Western Medicine, 237 Traditional Chinese Medi-
cine prescriptions were investigated and Honghua (Flos
Carthami) was one of the herbs with the highest fre-
quency of use.14 In our study, the Honghua (Flos Car-
thami) extracts were prepared according to the meth-
ods for preparing Honghua (Flos Carthami) injection
as established by CFDA. Currently, Honghua (Flos Car-
thami) injection plays a positive role in treating DM
and its complications.2 Clinical studies have shown
that Honghua (Flos Carthami) injection can effectively
slow down the development of diabetic nephropathy,
and significantly reduce fasting blood glucose of pa-
tients.15
Studies have shown that patients with type Ⅱ DM
have a higher level of LPS compared with control
groups.16 A db/db type Ⅱ diabetic mouse model was
used to determine the level of LPS in the intestinal
Table 3 Inhibitory effect of Honghua (Flos Carthami) on yeast α-glucosidase activities
Group
Honghua (Flos Carthami)
Acarbose
Concentration (µg/mL)
125
62.5
31.3
15.6
2.5
1.3
0.6
0.3
Percentage of inhibition (%)
89.8±5.6
66.9±5.1
46.6±3.7
22.8±3.1
70.2±3.2
34.0±2.7
24.4±1.7
12.9±1.2
IC50 (µg/mL)
32.8±5.7a
1.8±0.4
Notes: Honghua (Flos Carthami) was treated with Honghua (Flos Carthami), α-glucosidase, substrate, and sodium glycinate; Acarbose was
the positive control with acarbose and others were same as Honghua (Flos Carthami). IC50: half maximal (50%) inhibitory concentration
on yeast α-glucosidase activities. aP<0.001, compared with acarbose control.
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tract and portal blood, and the results showed that the
level of LPS was positively correlated with the blood
glucose.17 In the present study, LPS was used to induce
RAW 264.7 cells to produce NO. It was reported that
curcumin decreased the amount of iNOS protein by af-
fecting the LPS-induced iNOS transcription level.7 As
a positive control, curcumin could decrease the level of
nitrite and the production of NO at 2 and 4 µg/mL.
We also showed that the Honghua (Flos Carthami) ex-
tracts could inhibit the production of NO, and there
were significant inhibitory effects at concentrations of
25, 50, and 100 µg/mL.
The main components of Honghua (Flos Carthami)
are flavonols and chalcones, which are flavonoids.
These two types of compound have significant pharma-
cological activity both in vivo and in vitro. The most
common flavonols are kaempferol and quercetin,
which have relatively stable structures, and are often
used as index components in content determination.
The content of total flavonoids in the extracts was de-
termined according to the new standard established in
2012 for Honghua (Flos Carthami) injection.6 Under
the experimental conditions of this study, the content
of total flavonoids in 1 mL of the Honghua (Flos Car-
thami) extract solution (equivalent to 0.5 g of crude
drug) was 0.57 mg on the basis of kaempferol.
Recent studies have shown that plant flavonoid compo-
nents protecting islet b-cells from damage is one of the
major mechanisms of action of flavonoids in DM treat-
ment.18 In addition, many plant flavonoid components
can act as α-glucosidase inhibitors.18 For example, lico-
rice was shown to improve the activity of antioxidant
enzymes in the blood of type Ⅱ DM rats, thereby re-
ducing the basal values of blood glucose and urine glu-
cose of the experimental rats.19 Other studies showed
that the total flavonoids from buckwheat flower could
achieve a hypoglycemic effect by inhibiting the activity
of α-glucosidase.20
In this study, 4-MUG was used as an active substrate,
which when hydrolyzed by α-glucosidase to 4-MU,
was detected by its fluorescence. Currently, there is no
report in China on a method for screening α-glucosi-
dase inhibitors by fluorescence analysis. In our study,
acarbose was used as a positive control, which is com-
monly used clinically to relieve postprandial hypergly-
cemia. The results showed that the IC50 value of acar-
bose was (1.8 ± 0.4) µg/mL. The Honghua (Flos Car-
thami) extract inhibited the activity of α-glucosidase
within the concentration range of 15.6-125 µg/mL,
and had an IC50 value of (32.8±5.7) µg/mL, which was
about 19-fold higher than that of acarbose. Although
the inhibitory effect of Honghua (Flos Carthami) onα-glucosidase activity was significantly lower than that
of pure acarbose, the Honghua (Flos Carthami) extracts
used in this study was a crude extract so it is certainly
worth being further studied.
Flavonoids can effectively prevent and treat DM and
its complications through various pathways such as pro-
moting the regeneration of islet b-cells, inhibiting the
activity of α-glucosidase, slowing down the absorption
of glucose by the intestinal tract, improving the sensi-
tivity of the body to insulin, and promoting the use of
glucose by peripheral tissues.18 Whether the clinical ef-
fects of Honghua (Flos Carthami) injection for treating
DM are achieved by protecting islet b-cells and wheth-
er the effect of inhibiting the generation of NO from
LPS-activated RAW 264.7 cells in vitro can be repro-
duced in an animal experiment need to be studied.
The new standard established by CFDA in 2012 speci-
fies that the content of total flavonoids in 1 mL of
Honghua (Flos Carthami) injection ranges from 0.20
to 0.70 mg.6 Our further studies will also focus on the
relationship between the content of total flavonoids
and the pharmacological activity shown within this
range. It was reported that some serotonin derivatives
found in the seed of Carthamus tinctorius L. acted asα-glucosidase inhibitors.21 We will investigate if these
compounds exist in Honghua (Flos Carthami), and
identify other active constituents.
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